Dysregulation of CTSS activity was also recently reported for hematological malignancies: CTSS mutations, such as the recurrent Y132D hotspot in follicular lymphoma, enhance enzymatic activity and modulate antigen processing, influencing both CD4+ and CD8+ T cell-mediated responses [84]. Here, CTSS is linked to hematologic disorder.